There are 2789 resources available
1315P - Impact of high fasting plasma glucose in the clinical outcome of patients with advanced NSCLC with PD-L1 ≥ 50% treated with frontline pembrolizumab
Presenter: Sandra Llop Serna
Session: ePoster Display
1278P - SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, as first-line therapy for PD-L1+ advanced/metastatic NSCLC: Data from a clinical expansion cohort of a phase I study
Presenter: Jifeng Feng
Session: ePoster Display
1279P - The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)
Presenter: Alexander Meisel
Session: ePoster Display
1280P - Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
Presenter: Qing Zhou
Session: ePoster Display
1282P - Biology of immune resistance in oncogenic driven advanced non-small cell lung cancer (aNSCLC)
Presenter: Mihaela Aldea
Session: ePoster Display
1283P - Predicting the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) by combining clinical and radiomic features
Presenter: Fariba Tohidinezhad
Session: ePoster Display
1321P - Real-world treatments and clinical outcomes in advanced NSCLC without actionable mutations after introduction of immunotherapy (IO) in Japan
Presenter: Hiroshi Nokihara
Session: ePoster Display
1322P - Development and external validation of a novel four-gene-pair signature for predicting clinical response to anti-PD-1 immunotherapy of non-small cell lung cancer
Presenter: Chengming Liu
Session: ePoster Display
1286P - Senescent immune phenotype (SIP) status predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients
Presenter: Marie Naigeon
Session: ePoster Display
1287P - Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy
Presenter: Jacobo Rogado
Session: ePoster Display